Delivery Order SPE2DB22D3009-SPE2DB25FAQ21

Award Date 1/31/25
Potential Completion Date 2/3/25
Potential Value $2.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $5,322.46, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the provision of TETRACAINE 0.5% STERI-UNIT SOL 4ML, with an ultimate completion date of March 12, 2024. The contract type is Firm Fixed Price. This award is not associated with a set-aside program. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,351.05 firm fixed-price delivery order is for the supply of 4558843937 - TETRACAINE 0.5% STERI-UNIT SOL 4ML. The contract has an ultimate completion date of October 24, 2022 and was awarded on October 21, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $4,920.98, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TETRACAINE 0.5% STERI-UNIT SOL 4ML, a medical product, and has an ultimate completion date of January 15, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of TETRACAINE 0.5% EYE 1S medication with a ceiling value of $4,133.59. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of February 28, 2025. The contract is not designated with a set-aside and was awarded on...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award has a Ceiling Value of $2,799.06 and is a Delivery Order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the delivery of Tetracaine 0.5% Steri-Unit Solution in 4ml vials. The contract is a Delivery Order with a Firm Fixed Price of $1,296.49 and an ultimate completion date of August 15, 2024. This award is not a set-aside contract. Amerisourcebergen has been awarded numerous Indefinite Delivery Contracts (IDCs) by the DLA and other federal...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $32,130.46 firm fixed-price delivery order is for the supply of TETRACAIN HCL 0.5% 12S, a medical product, to support military healthcare programs. The contract has an ultimate completion date of March 21, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Tetracaine 0.5% Steri-Unit Solution (4 ml). The $1,883.35 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) on February 23, 2022, with a completion date of February 24, 2022. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has a significant $999,999,999...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $15,498.44, is for the delivery of Tetracain HCL 0.5% 12S, a pharmaceutical product, to support federal healthcare programs. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,269.50, is for the delivery of Tetracaine 0.5% Steri-Unit Solution, 4 ml. The contract is a firm fixed-price delivery order with a period of performance through May 9, 2024. The contract does not have a set-aside designation, indicating it was competitively awarded....
  • SPE2DB22D3009
    Indefinite Delivery Contract
  • SPE2DB22D3009-SPE2DB25FAQ21
    Delivery Order

This federal contract award, valued at $2,773.35, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TETRACAINE 0.5% STERI-UNIT SOL 4ML, a medical product. It is a firm fixed-price delivery order contract with a completion date of February 3, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.

Generated 5/2/25, 10:16 AM